CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice
Editorial Archive

Magnesium Alloys: Revolutionising the Pharmaceutical Industry

The pharmaceutical industry has been growing by 7.8% year on year, and its worth is estimated to be $1.6 trillion by 2020. However, the pharmaceutical industry...
Continue Reading →
How Much Energy Do You Throw Away Aft er Lights Out?
Editorial Archive

How Much Energy Do You Throw Away Aft er Lights Out?

When the last person out at night turns off the lights, how many of us are lulled into a false sense of security into thinking that the energy consumption of o...
Continue Reading →
The Big Data Cure-all?
Editorial Archive

The Big Data Cure-all?

Data management is an issue for any business these days, but particularly in life sciences where growing regulatory demands and commercial pressures are increa...
Continue Reading →
Comparison of Marketing Authorisation and its Requirements for Singapore and Thailand
Editorial Archive

Comparison of Marketing Authorisation and its Requirements for Singapore and Thailand

The availability of generic medication is an important issue in the ASEAN regions. The regulatory requirements of various countries of the world vary from each...
Continue Reading →
Tamper-evidence – A Vital Matter of Safet
Editorial Archive

Tamper-evidence – A Vital Matter of Safet

This article, written by Alessio Bressan at IGGB and starting from the concept of falsified medicine as postulated in the European directive, focuses on the opti...
Continue Reading →
It’s Time to Address the Claims Management Disconnect
Editorial Archive

It’s Time to Address the Claims Management Disconnect

One of the fundamental pillars of the life sciences industry is the accuracy of the claims that it makes for its products. Over decades, the industry has strived...
Continue Reading →
Life Sciences in Asia – Nick Stephens, RSA
Editorial Archive

Life Sciences in Asia – Nick Stephens, RSA

Is the Tiger an Endangered Species? The story of Western expansion into the life sciences in Asia has been one of rapid change. Nick Stephens, Executive Chairman of ...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026